Introduction Semaglutide Has emerged as a revolutionary treatment for individuals dealing with type 2 diabetes, obesity, and related cardiovascular conditions. This medication, classified as a GLP-1 receptor agonist, mimics the natural hormone glucagon-like peptide-1 (GLP-1), which plays a crucial role in regulating insulin secretion, blood sugar levels, and appetite. Initially https://best-oncologist-in-india71480.blogrelation.com/37600468/semaglutide-a-breakthrough-in-managing-diabetes-obesity-and-cardiovascular-health